novo nordisk glp 1 products Novo, Lilly buoyed by fast-growing GLP-1 drug sales Novo's Wegovy becomes first GLP-1

Read the full Q&A to learn how this discovery could expand treatment options for metabolic health.

While GLP-1 receptor agonists dominate modern weight management, other medication classes offer distinct mechanisms for addressing obesity

Each ingredient is clinically validated to support fat oxidation, blood sugar stability, and appetite control while boosting overall performance

GLP-1 weight loss medications show powerful results, but digestive side effects may affect comfort and quality of life for some patients.

However, these behavioural interventions alone may not achieve disease regression or remission, and maintaining long-term ...